<p>根據最近向證券交易委員會的披露，Sequoia Financial Advisors LLC 在第四季度將其在 Align Technology, Inc.（NASDAQ:ALGN - 免費報告）股票中的持股比例提高了 320.1%。該機構投資者在季度內購買了 6,085 股後，持有 7,986 股該醫療設備提供商的股票。根據其最近向證券交易委員會的備案，Sequoia Financial Advisors LLC 在 Align Technology 的持股價值為 1,247,000 美元。</p>
<p>獲取 <strong>Align Technology</strong> 的提醒：</p>
<ul>
<li>為什麼這三隻科技股票可能是你忽視的最佳機會</li>
</ul>
<p>其他一些機構投資者最近也增加或減少了對該股票的持股。Capital International Investors 在第三季度將其在 Align Technology 的持股比例提高了 88.6%。Capital International Investors 現在擁有 3,050,373 股該醫療設備提供商的股票，價值 381,968,000 美元，在上個季度又購買了 1,433,393 股。Holocene Advisors LP 在第三季度獲得了 Align Technology 的新頭寸，價值 179,035,000 美元。美國銀行在第三季度將其在 Align Technology 的持股比例提高了 72.0%。美國銀行現在擁有 1,353,125 股該醫療設備提供商的股票，價值 169,438,000 美元，在上個季度又購買了 566,488 股。Invesco Ltd.在第三季度將其在 Align Technology 的持股比例提高了 37.4%。Invesco Ltd.現在擁有 1,497,535 股該醫療設備提供商的股票，價值 187,521,000 美元，在上個季度又購買了 407,559 股。最後，瑞銀集團在第三季度將其在 Align Technology 的持股比例提高了 122.4%。瑞銀集團現在擁有 581,307 股該醫療設備提供商的股票，價值 72,791,000 美元，在上個季度又購買了 319,908 股。88.43% 的股票由機構投資者和對沖基金持有。</p>
<h2>內部人士下注</h2>
<p>在其他 Align Technology 的新聞中，執行副總裁 John Morici 於 2 月 18 日星期三出售了 7,969 股該股票。股票以平均價格 189.31 美元出售，總價值為 1,508,611.39 美元。交易後，該執行副總裁直接持有 8,237 股公司的股票，價值 1,559,346.47 美元。這代表其持股減少了 49.17%。該交易在向證券交易委員會的法律文件中披露，文件可通過此超鏈接獲取。當前 0.75% 的股票由公司內部人士持有。</p>
<h2>分析師設定新目標價</h2>
<ul>
<li>買入抄底？這些盈利失誤提供長期上漲潛力</li>
</ul>
<p>幾位研究分析師對該公司發佈了報告。摩根士丹利將 Align Technology 的目標價從 169.00 美元上調至 188.00 美元，並在 4 月 24 日的報告中給予該股票 “持平” 評級。巴克萊將 Align Technology 的評級從 “持平” 上調至 “增持”，並在 3 月 17 日的報告中設定了 200.00 美元的目標價。瑞穗將 Align Technology 的目標價從 200.00 美元上調至 215.00 美元，並在 2 月 5 日的報告中給予該股票 “跑贏大盤” 評級。傑富瑞金融集團將 Align Technology 的目標價從 155.00 美元上調至 185.00 美元，並在 2 月 5 日的研究報告中給予該公司 “持有” 評級。最後，羅伯特·W·貝爾德在 2 月 5 日的研究報告中設定了 Align Technology 的目標價為 218.00 美元。八位投資分析師對該股票給予了買入評級，六位分析師對該公司的股票給予了持有評級。根據 MarketBeat.com 的數據，Align Technology 的共識評級為 “適度買入”，共識目標價為 205.85 美元。</p>
<p><strong>查看我們對 ALGN 的最新分析</strong></p>
<h2>Align Technology 價格表現</h2>
<ul>
<li>MarketBeat 週迴顧：12/25 - 12/29</li>
</ul>
<p>Align Technology 的股票在星期三開盤價為 165.79 美元。該公司的 50 日移動平均線為 176.74 美元，200 日移動平均線為 166.00 美元。Align Technology, Inc.的股價在一年內最低為 122.00 美元，最高為 208.30 美元。該公司的市值為 118.7 億美元，市盈率為 27.82，市盈增長比率為 1.69，貝塔值為 1.70。</p>
<p>Align Technology（NASDAQ:ALGN - 獲取免費報告）最近於 4 月 29 日發佈了季度財報。該醫療設備提供商報告季度每股收益為 2.58 美元，超出分析師共識預期的 2.26 美元，超出幅度為 0.32 美元。Align Technology 的淨利潤率為 10.50%，股本回報率為 15.82%。該公司在季度內的收入為 10.4 億美元，而共識預期為 10.2 億美元。在去年同期，該公司發佈的每股收益為 2.13 美元。該公司的季度收入同比增長 6.2%。整體來看，賣方分析師預計 Align Technology, Inc.在當前年度將發佈每股收益 9.47 美元。</p>
<p>Align Technology 宣佈其董事會已於 4 月 29 日批准了一項股票回購計劃，允許公司回購 2 億美元的流通股。該回購授權允許該醫療設備提供商通過公開市場購買最多 1.6% 的股份。股票回購計劃通常表明公司的管理層認為其股票被低估。</p>
<h2>Align Technology 公司簡介</h2>
<p>（免費報告）</p>
<p>Align Technology, Inc. NASDAQ: ALGN 通過開發 Invisalign 系統，開創了數字技術在正畸學中的應用，該系統是一系列透明、可拆卸的矯正器，為傳統金屬牙套提供了一種替代方案。自 1997 年由 Zia Chishti 和 Kelsey Wirth 創立以來，總部位於亞利桑那州坦佩的公司已將其關注點擴展到包括口腔內掃描儀、牙科實驗室的 CAD/CAM 軟件和全面的數字牙科解決方案。</p>
<p>公司的標誌性 Invisalign 系統利用 3D 成像和計算機輔助設計 (CAD) 創建定製的矯正器，逐漸重新定位牙齒，提高患者的舒適度和治療的可預測性。</p>
<h2>推薦故事</h2>
<ul>
<li>五隻我們認為比 Align Technology 更好的股票</li>
<li>海軍催化劑點燃 Odysight 的增長引擎</li>
<li>AST SpaceMobile 因銀河第一季度業績不佳而暴跌：垂直整合能拯救這家 SpaceX 競爭對手嗎？</li>
<li>Axon 在盈利後大幅上漲，但仍比高點下跌超過 50%</li>
<li>可能重新定義蘋果夏季反彈的事件</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxHTg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxHTg"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在 Align Technology 嗎？</h2>
<p>在考慮 Align Technology 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已確定五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Align Technology 並不在名單上。</p>
<p>雖然 Align Technology 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

愛齊科技

標普健康醫療設備 ETF - SPDR

醫療業 ETF - SPDR

美國醫藥設備 ETF - iShares

<p>Sequoia Financial Advisors LLC 在第四季度將其在 Align Technology, Inc. (NASDAQ:ALGN) 的持股增加了 320.1%，目前持有 7,986 股，價值 125 萬美元。其他機構投資者也增加了他們的持股，Capital International Investors 的持股增加了 88.6%。分析師們為 Align Technology 設定了新的價格目標，普遍目標為 205.85 美元。該股票開盤價為 165.79 美元，市值為 118.7 億美元，市盈率為 27.82。Align 在上個季度報告的每股收益為 2.58 美元，超出預期</p>

<p>Sequoia Financial Advisors LLC raised its stake in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 320.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,986 shares of the medical equipment provider's stock after purchasing an additional 6,085 shares during the quarter. Sequoia Financial Advisors LLC's holdings in Align Technology were worth $1,247,000 as of its most recent filing with the Securities and Exchange Commission.</p>
<div class="lb-trans"><p>根據最近向證券交易委員會的披露，Sequoia Financial Advisors LLC 在第四季度將其在 Align Technology, Inc.（NASDAQ:ALGN - 免費報告）股票中的持股比例提高了 320.1%。該機構投資者在季度內購買了 6,085 股後，持有 7,986 股該醫療設備提供商的股票。根據其最近向證券交易委員會的備案，Sequoia Financial Advisors LLC 在 Align Technology 的持股價值為 1,247,000 美元。</p>
</div><p>Get <strong>Align Technology</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Align Technology</strong> 的提醒：</p>
</div><ul>
<li>Why These 3 Tech Stocks Could Be the Best Opportunities You're Overlooking</li>
</ul>
<div class="lb-trans"><ul>
<li>為什麼這三隻科技股票可能是你忽視的最佳機會</li>
</ul>
</div><p>A number of other institutional investors also recently added to or reduced their stakes in the stock. Capital International Investors boosted its holdings in shares of Align Technology by 88.6% in the 3rd quarter. Capital International Investors now owns 3,050,373 shares of the medical equipment provider's stock worth $381,968,000 after acquiring an additional 1,433,393 shares in the last quarter. Holocene Advisors LP acquired a new position in Align Technology during the 3rd quarter worth $179,035,000. Bank of America Corp DE lifted its holdings in Align Technology by 72.0% during the 3rd quarter. Bank of America Corp DE now owns 1,353,125 shares of the medical equipment provider's stock worth $169,438,000 after buying an additional 566,488 shares in the last quarter. Invesco Ltd. lifted its holdings in Align Technology by 37.4% during the 3rd quarter. Invesco Ltd. now owns 1,497,535 shares of the medical equipment provider's stock worth $187,521,000 after buying an additional 407,559 shares in the last quarter. Finally, UBS Group AG lifted its holdings in Align Technology by 122.4% during the 3rd quarter. UBS Group AG now owns 581,307 shares of the medical equipment provider's stock worth $72,791,000 after buying an additional 319,908 shares in the last quarter. 88.43% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他一些機構投資者最近也增加或減少了對該股票的持股。Capital International Investors 在第三季度將其在 Align Technology 的持股比例提高了 88.6%。Capital International Investors 現在擁有 3,050,373 股該醫療設備提供商的股票，價值 381,968,000 美元，在上個季度又購買了 1,433,393 股。Holocene Advisors LP 在第三季度獲得了 Align Technology 的新頭寸，價值 179,035,000 美元。美國銀行在第三季度將其在 Align Technology 的持股比例提高了 72.0%。美國銀行現在擁有 1,353,125 股該醫療設備提供商的股票，價值 169,438,000 美元，在上個季度又購買了 566,488 股。Invesco Ltd.在第三季度將其在 Align Technology 的持股比例提高了 37.4%。Invesco Ltd.現在擁有 1,497,535 股該醫療設備提供商的股票，價值 187,521,000 美元，在上個季度又購買了 407,559 股。最後，瑞銀集團在第三季度將其在 Align Technology 的持股比例提高了 122.4%。瑞銀集團現在擁有 581,307 股該醫療設備提供商的股票，價值 72,791,000 美元，在上個季度又購買了 319,908 股。88.43% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>內部人士下注</h2>
</div><p>In other Align Technology news, EVP John Morici sold 7,969 shares of the stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $189.31, for a total value of $1,508,611.39. Following the transaction, the executive vice president directly owned 8,237 shares of the company's stock, valued at $1,559,346.47. This represents a 49.17% decrease in their position. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through this hyperlink. 0.75% of the stock is currently owned by corporate insiders.</p>
<div class="lb-trans"><p>在其他 Align Technology 的新聞中，執行副總裁 John Morici 於 2 月 18 日星期三出售了 7,969 股該股票。股票以平均價格 189.31 美元出售，總價值為 1,508,611.39 美元。交易後，該執行副總裁直接持有 8,237 股公司的股票，價值 1,559,346.47 美元。這代表其持股減少了 49.17%。該交易在向證券交易委員會的法律文件中披露，文件可通過此超鏈接獲取。當前 0.75% 的股票由公司內部人士持有。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><ul>
<li>Buy the Dip? These Earnings Misses Offer Long-Term Upside</li>
</ul>
<div class="lb-trans"><ul>
<li>買入抄底？這些盈利失誤提供長期上漲潛力</li>
</ul>
</div><p>Several research analysts have issued reports on the company. Morgan Stanley upped their price objective on Align Technology from $169.00 to $188.00 and gave the stock an &#34;equal weight&#34; rating in a report on Friday, April 24th. Barclays raised Align Technology from an &#34;equal weight&#34; rating to an &#34;overweight&#34; rating and set a $200.00 price objective on the stock in a report on Tuesday, March 17th. Mizuho upped their price objective on Align Technology from $200.00 to $215.00 and gave the stock an &#34;outperform&#34; rating in a report on Thursday, February 5th. Jefferies Financial Group upped their target price on shares of Align Technology from $155.00 to $185.00 and gave the company a &#34;hold&#34; rating in a research report on Thursday, February 5th. Finally, Robert W. Baird set a $218.00 target price on shares of Align Technology in a research report on Thursday, February 5th. Eight investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Align Technology has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $205.85.</p>
<div class="lb-trans"><p>幾位研究分析師對該公司發佈了報告。摩根士丹利將 Align Technology 的目標價從 169.00 美元上調至 188.00 美元，並在 4 月 24 日的報告中給予該股票 “持平” 評級。巴克萊將 Align Technology 的評級從 “持平” 上調至 “增持”，並在 3 月 17 日的報告中設定了 200.00 美元的目標價。瑞穗將 Align Technology 的目標價從 200.00 美元上調至 215.00 美元，並在 2 月 5 日的報告中給予該股票 “跑贏大盤” 評級。傑富瑞金融集團將 Align Technology 的目標價從 155.00 美元上調至 185.00 美元，並在 2 月 5 日的研究報告中給予該公司 “持有” 評級。最後，羅伯特·W·貝爾德在 2 月 5 日的研究報告中設定了 Align Technology 的目標價為 218.00 美元。八位投資分析師對該股票給予了買入評級，六位分析師對該公司的股票給予了持有評級。根據 MarketBeat.com 的數據，Align Technology 的共識評級為 “適度買入”，共識目標價為 205.85 美元。</p>
</div><p><strong>Check Out Our Latest Analysis on ALGN</strong></p>
<div class="lb-trans"><p><strong>查看我們對 ALGN 的最新分析</strong></p>
</div><h2>Align Technology Price Performance</h2>
<div class="lb-trans"><h2>Align Technology 價格表現</h2>
</div><ul>
<li>MarketBeat Week in Review: 12/25 - 12/29</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧：12/25 - 12/29</li>
</ul>
</div><p>Align Technology stock opened at $165.79 on Wednesday. The firm has a 50-day moving average of $176.74 and a 200-day moving average of $166.00. Align Technology, Inc. has a one year low of $122.00 and a one year high of $208.30. The company has a market cap of $11.87 billion, a price-to-earnings ratio of 27.82, a P/E/G ratio of 1.69 and a beta of 1.70.</p>
<div class="lb-trans"><p>Align Technology 的股票在星期三開盤價為 165.79 美元。該公司的 50 日移動平均線為 176.74 美元，200 日移動平均線為 166.00 美元。Align Technology, Inc.的股價在一年內最低為 122.00 美元，最高為 208.30 美元。該公司的市值為 118.7 億美元，市盈率為 27.82，市盈增長比率為 1.69，貝塔值為 1.70。</p>
</div><p>Align Technology (NASDAQ:ALGN - Get Free Report) last posted its quarterly earnings data on Wednesday, April 29th. The medical equipment provider reported $2.58 EPS for the quarter, topping analysts' consensus estimates of $2.26 by $0.32. Align Technology had a net margin of 10.50% and a return on equity of 15.82%. The company had revenue of $1.04 billion during the quarter, compared to the consensus estimate of $1.02 billion. During the same period in the prior year, the business posted $2.13 EPS. The company's quarterly revenue was up 6.2% on a year-over-year basis. As a group, sell-side analysts expect that Align Technology, Inc. will post 9.47 earnings per share for the current year.</p>
<div class="lb-trans"><p>Align Technology（NASDAQ:ALGN - 獲取免費報告）最近於 4 月 29 日發佈了季度財報。該醫療設備提供商報告季度每股收益為 2.58 美元，超出分析師共識預期的 2.26 美元，超出幅度為 0.32 美元。Align Technology 的淨利潤率為 10.50%，股本回報率為 15.82%。該公司在季度內的收入為 10.4 億美元，而共識預期為 10.2 億美元。在去年同期，該公司發佈的每股收益為 2.13 美元。該公司的季度收入同比增長 6.2%。整體來看，賣方分析師預計 Align Technology, Inc.在當前年度將發佈每股收益 9.47 美元。</p>
</div><p>Align Technology declared that its Board of Directors has approved a stock buyback program on Wednesday, April 29th that allows the company to buyback $200.00 million in outstanding shares. This buyback authorization allows the medical equipment provider to purchase up to 1.6% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's management believes its shares are undervalued.</p>
<div class="lb-trans"><p>Align Technology 宣佈其董事會已於 4 月 29 日批准了一項股票回購計劃，允許公司回購 2 億美元的流通股。該回購授權允許該醫療設備提供商通過公開市場購買最多 1.6% 的股份。股票回購計劃通常表明公司的管理層認為其股票被低估。</p>
</div><h2>Align Technology Company Profile</h2>
<div class="lb-trans"><h2>Align Technology 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Align Technology, Inc NASDAQ: ALGN pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.</p>
<div class="lb-trans"><p>Align Technology, Inc. NASDAQ: ALGN 通過開發 Invisalign 系統，開創了數字技術在正畸學中的應用，該系統是一系列透明、可拆卸的矯正器，為傳統金屬牙套提供了一種替代方案。自 1997 年由 Zia Chishti 和 Kelsey Wirth 創立以來，總部位於亞利桑那州坦佩的公司已將其關注點擴展到包括口腔內掃描儀、牙科實驗室的 CAD/CAM 軟件和全面的數字牙科解決方案。</p>
</div><p>The company's signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.</p>
<div class="lb-trans"><p>公司的標誌性 Invisalign 系統利用 3D 成像和計算機輔助設計 (CAD) 創建定製的矯正器，逐漸重新定位牙齒，提高患者的舒適度和治療的可預測性。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than Align Technology</li>
<li>Navy Catalyst Ignites Odysight’s Growth Engine</li>
<li>AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?</li>
<li>Axon Surged After Earnings and Is Still Down Over 50% From Highs</li>
<li>The Event That Could Redefine Apple’s Summer Rally</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比 Align Technology 更好的股票</li>
<li>海軍催化劑點燃 Odysight 的增長引擎</li>
<li>AST SpaceMobile 因銀河第一季度業績不佳而暴跌：垂直整合能拯救這家 SpaceX 競爭對手嗎？</li>
<li>Axon 在盈利後大幅上漲，但仍比高點下跌超過 50%</li>
<li>可能重新定義蘋果夏季反彈的事件</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxHTg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=ALGN"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Align Technology Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Align Technology 嗎？</h2>
</div><p>Before you consider Align Technology, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Align Technology 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Align Technology wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已確定五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Align Technology 並不在名單上。</p>
</div><p>While Align Technology currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Align Technology 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Sequoia Financial Advisors LLC Has $1.25 Million Stock Position in Align Technology, Inc. $ALGN

Market Beat

美國銀行

景順投資管理

瑞銀集團

摩根士丹利

巴克萊銀行

瑞穗金融集團

Mizuho Financial Group, Inc.

Jefferies Financial

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

紅杉金融顧問有限公司在愛齊科技公司持有價值 125 萬美元的股票頭寸